Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance.
Journal Information
Full Title: Antimicrob Agents Chemother
Abbreviation: Antimicrob Agents Chemother
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Anti-Infective Agents
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"data availability all raw sequencing data are available in the national center for biotechnology information (ncbi) short read archive (sra) under bioproject prjna1035781 (accession numbers srr26669148 to srr26669387 ). data availability all raw sequencing data are available in the national center for biotechnology information (ncbi) short read archive (sra) under bioproject prjna1035781"
"J.S., J.M.G., N.M., J.H., B.H., K.C.K., P.M., and S.L.G. are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, and may own and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA."
"This work was supported by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025